BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bekhet MA, Ali AA, Kharshoum RM, El-ela FIA, Salem HF. Intranasal Niosomal in situ Gel as a Novel Strategy for Improving Citicoline Efficacy and Brain Delivery in Treatment of Epilepsy: In vitro and ex vivo characterization and in vivo pharmacodynamics investigation. Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.xphs.2022.02.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Patel D, Thakkar H. Formulation considerations for improving intranasal delivery of CNS acting therapeutics. Therapeutic Delivery 2022. [DOI: 10.4155/tde-2022-0018] [Reference Citation Analysis]
2 Margari A, Monteduro AG, Rizzato S, Capobianco L, Crestini A, Rivabene R, Piscopo P, D’onofrio M, Manzini V, Trapani G, Quarta A, Maruccio G, Ventra C, Lieto L, Trapani A. The Encapsulation of Citicoline within Solid Lipid Nanoparticles Enhances Its Capability to Counteract the 6-Hydroxydopamine-Induced Cytotoxicity in Human Neuroblastoma SH-SY5Y Cells. Pharmaceutics 2022;14:1827. [DOI: 10.3390/pharmaceutics14091827] [Reference Citation Analysis]
3 Yasamineh S, Yasamineh P, Ghafouri Kalajahi H, Gholizadeh O, Yekanipour Z, Afkhami H, Eslami M, Hossein Kheirkhah A, Taghizadeh M, Yazdani Y, Dadashpour M. A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system. Int J Pharm 2022;:121878. [PMID: 35636629 DOI: 10.1016/j.ijpharm.2022.121878] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]